key: cord-0794526-8a0y2guj
authors: Manes, Nathan P.; Nita-Lazar, Aleksandra
title: Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways
date: 2021-06-29
journal: mSystems
DOI: 10.1128/msystems.00336-21
sha: f4002eb626a9efb251279a7fea4e71db790bcfad
doc_id: 794526
cord_uid: 8a0y2guj

Pattern recognition receptors (PRRs) form the front line of defense against pathogens. Many of the molecular mechanisms that facilitate PRR signaling have been characterized in detail, which is critical for the development of accurate PRR pathway models at the molecular interaction level. These models could support the development of therapeutics for numerous diseases, including sepsis and COVID-19. This review describes the molecular mechanisms of the principal signaling interactions of the Toll-like receptor, STING, MAVS, and inflammasome pathways. A detailed molecular mechanism network is included as Data Set S1 in the supplemental material.

The network includes transcription factor-target gene relationships for cytokines and PRR pathway proteins. These could support the modeling of transcription and translation and enable longer (in silico time) pathway simulations. These transcription factor-target gene relationships were constructed using data from two online databases. CytReg (downloaded 2 June 2021; http://cytreg.bu.edu) (23) was used to model transcription factor-mediated expression of cytokines. RegNetwork (downloaded 2 June 2021; http:// www.regnetworkweb.org) (24) was used to model transcription factor-mediated expression of PRR pathway proteins (except for cytokines). Proteins were not included if they were outside the PRR pathways (e.g., metabolic enzyme expression affected by the mitogen-activated protein kinase [MAPK]-activated transcription factors).

TLRs are a class of dimeric PRRs which sense a variety of extracellular and endosomal PAMPs and DAMPs and initiate signal transduction resulting in transcriptional FIG 2 The PRR pathway network. The PRR network (see Data Set S1) is depicted. The network includes both the human and the mouse interactions. Two subnetworks of this network (the TLR4 pathway and the cytosolic PRR pathways) are shown in Fig. S1 and S2. reprogramming or programmed cell death (25) (26) (27) (28) . The vertebrate TLR family of genes contains at least 27 members, of which 13 are found in the mammalian TLR family (29) .

Humans express TLR1 to TLR10, whereas mice express TLR1 to TLR9 and TLR11 to TLR13 (29) . One or more PAMPs have been discovered for all 13 mammalian TLRs, and DAMPs have been discovered for almost all 13 (29) (30) (31) (32) (33) (34) . Human TLRs have been reported to bind 46 distinct ligands of natural origin (PRRDB v2; downloaded 2 June 2021; interaction in $2 entries; https://webs.iiitd.edu .in/raghava/prrdb2/) (6) . Many TLR-ligand structures have been solved (35) (36) (37) (38) . Some TLR dimers bind to only a single ligand copy. For example, the TLR1-TLR2 heterodimer binds to only a single copy of triacyl-lipopeptide (35) .

TLR activation initiates a signal transduction which includes the MAPK phosphorylation cascade and the NF-k B pathway (25) (26) (27) (28) . This results in broad reprogramming of gene expression, resulting in physiological alterations related to metabolism, cell survival, cell stress, and cytokine signaling (25) (26) (27) (28) . Numerous pathogens express virulence factors that antagonize signaling proteins of the TLR pathway (39) .

TLR4 activation. Lipopolysaccharide (LPS) is a highly diverse class of molecules consisting of a lipid moiety, a core oligosaccharide moiety, and an O-antigen moiety (40) (41) (42) . The chemical structure of an LPS molecule determines its function. For example, Escherichia coli LPS is proinflammatory whereas Yersinia pestis LPS is anti-inflammatory after temperature-specific remodeling at 37°C (41) . Though energetically unfavorable, LPS sheds from bacterial outer membranes, binds LPS-binding protein (LBP), and then associates with CD14 (LBP of the LPS-LBP binds CD14, and then this complex reorganizes until LPS-CD14 releases LBP) (42) (43) (44) . CD14-bound LPS translocates to MD2, and LPS-MD2 binds a TLR4 monomer (43, 44) . Two copies of LPS-MD2-TLR4 can associate at their ectodomains and subsequently associate at their Toll/interleukin-1 (IL-1) receptor (TIR) domains (43) (44) (45) . A ligand-bound TLR4 cannot associate with an unbound copy at their ectodomains (45) .

Myddosome formation. The TIR domain of every mammalian TLR dimer except TLR3 can activate MyD88 and stimulate the formation of a myddosome (30) . TLR1, TLR2, TLR4, TLR6, and TLR9 first bind to TIR domain-containing adapter protein (MAL), and then the MAL TIR domain binds to and activates MyD88 (30, 46, 47) . The MAL TIR domain can oligomerize, and it is unclear if these oligomers can cause TLR clustering (46) (47) (48) . The MyD88 TIR domain can oligomerize beyond six subunits in vitro, but in a functional myddosome it may be limited to six copies (25, 46, 47, 49, 50) . Each MyD88 TIR domain is tethered to its death domain (DD), and the MyD88 hexamer DDs bind four copies of the interleukin-1 receptor-associated kinase 4 (IRAK4) via its DDs (25, 46, 47, 49) . Likewise, these four IRAK4 DDs each bind to either an IRAK1 DD or an IRAK2 (51) . The phospho-IRAK4 KD binds to and phosphorylates an IRAK1 DD or an IRAK2 DD (49, 51) . Eventually, the IRAK1/2 copies each become multiply phosphorylated, which destabilizes the myddosome (25, 49, 52) . The IRAK1/2 copies are released (possibly still bound to IRAK4 and Myd88) (25, 52) .

K63-M1 polyUb signaling. Active IRAK1/2 tetramers bind and activate the TRAF-C domain of tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) monomers (53, 54) . TRAF6 subsequently forms a homotrimer at the TRAF-C and coiled-coil (CC) domains (53, 54) . TRAF6 trimers subsequently dimerize at their RING domain, forming an active homohexamer which can homo-oligomerize (53, 54) . Activated TRAF6 is an E3 ubiquitin ligase which catalyzes K63-linked polyubiquitin (polyUb) onto numerous substrates including IRAK1, IRAK2, TRAF6, and NEMO (53) (54) (55) . Subsequently, the LUBAC complex (composed of HOIP, HOIL1, and Sharpin) catalyzes M1-linked polyubiquitination branches off the K63-linked chains (55, 56) .

TAB2 and TAB3 are components of a heterotrimer consisting of TAB1, TAK1, and either TAB2 or TAB3 (55) . TAK1 kinase activity is activated by TAB2/3 binding to K63-polyUb (55, 57) . TAK1 autophosphorylates itself (54) and initiates MAPK signaling by phosphorylating and activating MKK3, MKK4, MKK6, and MKK7 (58). These MKKs phosphorylate and activate p38a, p38b, p38g, p38d , JNK1, JNK2, and JNK3 (58). These MAPKs activate numerous transcription factors, broadly reprogramming transcription and affecting metabolism, growth, proliferation, programmed cell death, stress, immunity, chemotaxis, and differentiation (58) .

In addition, TAK1 phosphorylates nearby substrates that are also bound to K63-M1 polyubiquitin. NEMO (at its ubiquitin binding domain) binds to M1-polyUb (53-55, 57, 59) , and this step is critical for TAK1 activation of Ik B kinase alpha (IKKa) and IKKb (Ik B is short for inhibitor of NF-k B) and subsequent NF-k B pathway activation. IKKa, IKKb, and NEMO each form homodimers, and a NEMO homodimer (via its kinase binding domain) can bind to either an IKKa homodimer or an IKKb homodimer (via their NEMO binding domains) (53, 54, 59) . Additionally, the IKKa and IKKb homodimers can form higher-order homomeric complexes, and possibly also heteromeric complexes with each other. IKKa homodimers can trimerize (i.e., 6 copies total), and this complex can dimerize (i.e., 12 copies total; higher-order IKKa structures were not reported) (60) . IKKb homodimers can dimerize (i.e., 4 copies total), trimerize (i.e., 6 copies total), and form a variety of higher-order oligomers (61) . It remains unclear exactly which IKKa-IKKb-NEMO complexes form in vivo.

As mentioned above, NEMO binds to M1-polyUb. This brings IKKa/b into close proximity with TAK1. TAK1 phosphorylates and activates IKKa and IKKb (55, 56) . Activation of IKKa/b is completed via intracomplex trans-autophosphorylation (55, 56) . In addition to activating the NF-k B pathway, IKKb also activates MAPK signaling via TPL2 (see Data Set S1 in the supplemental material for details), resulting in broad transcriptional reprogramming (58) .

NF-k B pathway. NF-k B is a class of five dimeric transcription factors: NF-k B1, NFk B2, RelA, RelB, and c-Rel (54, 59, 62, 63) . Unlike the three Rel forms, NF-k B1 and NFk B2 lack a carboxy-terminal transactivation domain, and therefore, they cannot directly initiate transcription. Instead, the full-length forms of NF-k B1 and NF-k B2 (termed p105 and p100, respectively) each contain a carboxy-terminal ankyrin repeat domain (ARD). p105 processing into p50 is constitutive, whereas p100 processing into p52 is induced by its phosphorylation by IKKa (63) . There are 28 NF-k B dimeric forms (Data Set S1).

The Ik B family consists of nine members: p105, p100, Ik Ba, Ik Bb, Ik B« , Ik Bh , Ik Bz , Ik BNS, and BCL3 (59, 63) . The Ik B family members are all characterized by their ARD. The NF-k B family (including both forms of NF-k B1 and NF-k B2) all contain an aminoterminal Rel homology region (RHR) (54, 59, 62, 63) . The Ik B ARD regions can bind to NF-k B dimers (at the NF-k B RHR sequences) (54, 63) . This results in exactly 200 potential trimeric complexes (Data Set S1; not every combination is necessarily chemically possible). The cytosolic Ik B forms (p105, p100, Ik Ba, Ik Bb, and Ik B« ) inhibit NFk B by preventing its localization to the nucleus, whereas the nuclear Ik B forms (Ik Bh , Ik Bz , Ik BNS, and BCL3) can function by activating or inhibiting transcription (54, 62, 63) . Phosphorylation of the classical Ik B forms (Ik Ba, Ik Bb, and Ik B« ) by either IKKa or IKKb results in dissociation of the Ik B from the NF-k B RHR (54, 62, 63) . This enables nuclear import of the NF-k B and K48 polyubiquitination and degradation of the Ik B.

MyD88-independent TLR signaling. TLR3 and TLR4 can signal independently of MyD88, and both do so exclusively from the endosome (25, 27) . Activated TLR3 binds to and activates TIR domain-containing adapter molecule 1 (TRIF) directly (27, 64) . In contrast, activated endosomal TLR4 binds to and activates TIR domain-containing adapter molecule 2 (TRAM) (27, 32, 65, 66) . Subsequently, TRAM probably homodimerizes and/or homo-oligomerizes and then binds to and activates TRIF (32, (65) (66) (67) . TRIF probably homodimerizes and/or homo-oligomerizes and binds to and activates TRAF3 and TRAF6 (27, 32, (65) (66) (67) . Like TRAF6 (described above), activated TRAF3 forms a trimer, and then the trimers dimerize (i.e., six copies total), which enables its K63 E3 ubiquitin ligase activity (54) . It is unclear if TRAF3 and/or TRAF6 can form heteromers with each other or with other TRAFs (68) .

In addition to its K63-polyubiquitination signaling function, TRIF-bound TRAF3 also has a key role in signaling via IKK« and TBK1 (27) . TRAF3 binds to dimeric TRAF family member-associated NF-k B activator (TANK), and then TANK binds to dimeric IKK« , dimeric NEMO, and dimeric TBK1 (66) . TRAF3 probably K63-polyubiquitinates IKK« and TBK1, and then IKK« or TBK1 phosphorylates TRIF at its pLxIS motif (32, (69) (70) (71) (72) . The transcription factors IRF3 and (likely) IRF7 then bind to this motif and are phosphorylated and activated by IKK« or TBK1 (69, 73, 74) . IRF5 is activated via a different mechanism; it is phosphorylated and activated by IKKb (75) . The three IRFs dimerize, translocate to the nucleus, and activate transcription of immune response genes (69, 74).

As described above, a key outcome of TLR activation is the reprogramming of gene expression (another TLR-mediated effect is programmed cell death, described below). Notably, TLR activation upregulates the production and secretion of cytokines (26, 64) . For example, NF-k B upregulates the expression of interleukin-1 (IL-1), IL-2, IL-6, IL-8, IL-12, and TNF, which upregulate proliferation, inflammation, and angiogenesis (76) . TLR activation also upregulates the production and secretion of interferons, which can act in an autocrine or paracrine manner, resulting in the transcriptional reprogramming of a wide range of genes with diverse effects (74, 77) .

Programmed cell death. Successful human pathogens often express virulence factors to antagonize the host immune response (78) . For example, Yersinia pestis can enter host cells and secrete YopJ into the host cell cytosol which inhibits TAK1, IKKs, and MKKs, thereby blocking the NF-k B and MAPK pathways (78, 79) . To prevent the host cell from becoming a means to immune evasion and/or pathogen proliferation, the TLR pathway activates receptor-interacting serine/threonine-protein kinase 1 (RIPK1), which will cause programmed cell death if it is not deactivated by the NF-k B and MAPK pathways.

Activated TRIF binds to RIPK1 as well as to TRAF6 (78) . TRAF6 K63-polyubiquitinates and activates cIAP1 and cIAP2, which dimerize (70, 80, 81) . cIAP1/2 K63-polyubiquitinates RIPK1 (78) . Alternatively, activated TRIF binds to RIPK1, and RIPK1 homodimerizes and trans-autophosphorylates itself (82, 83) . RIPK1 might first oligomerize and then trans-autophosphorylate itself (84) (85) (86) . In a third option, RIPK1 can be phosphorylated and inhibited by numerous kinases (IKKa, IKKb, IKK« , TAK1, TBK1, and MK2) under various circumstances (see Data Set S1 for details). Absent this inhibition, each monomer of the autophosphorylated RIPK1 homodimer binds to and activates a copy of fatty acid synthase (FAS)-associated death domain protein (FADD) (83, 87) . Each of the two FADD copies binds to and activates a copy of caspase-8 (CASP8), and CASP8 transautoproteolyzes and activates itself (78, 83, (88) (89) (90) . Activated CASP8 proteolyzes and activates gasdermin-D (GSDMD) and GSDME, which form pores, ultimately triggering apoptosis (89) . Activated CASP8 also proteolyzes and activates the proinflammatory cytokines IL-1b and IL-18, which exit the cell through the pores (89) . RIPK1 can alternatively trigger necroptosis via RIPK3 and MLKL (see Data Set S1 for details).

STING pathway. Cyclic GMP-AMP synthase (cGAS) is an enzyme that is activated by binding to double-stranded DNA (dsDNA) originating from DNA viruses, retroviruses (via reverse transcription), bacteria, damaged mitochondria, phagocytosed dead cells, and host cell chromatin (e.g., via genomic instability and retrotransposons) (64, 91) . Upon DNA binding, cGAS homodimerizes and synthesizes cyclic-GMP(29-59)-AMP , which binds to and activates STING (which is a homodimeric transmembrane protein located at the endoplasmic reticulum [ER] or Golgi complex) (64, 91) . STING can also be activated by three bacterial cyclic dinucleotides: cyclic-di-AMP, cyclic-di-GMP, and 39,39-cyclic-GMP-AMP (92) . Activated STING binds to homodimeric TBK1, and this complex oligomerizes (91) . TBK1 trans-autophosphorylates and activates itself and then phosphorylates the STING pLxIS motif (69, 91) . IRF3 binds to this motif and is activated via a similar mechanism as TRIF (described above) (69, 91) .

MAVS pathway. Long (.1,000-bp) double-stranded viral RNA binds to multiple copies of MDA5 (64, (93) (94) (95) . Subsequently, TRIM25 and TRIM65 K63-polyubiquitinate MDA5, possibly causing it to homo-oligomerize (64, (94) (95) (96) . MAVS is a transmembrane protein of the outer mitochondrial membrane, its CARD domain is cytosolic, and one or both of the CARD domains of MDA5 bind to the CARD domain of monomeric MAVS (64, (93) (94) (95) . TRIM31 K63-polyubiquitinate MAVS, enabling it to oligomerize (96, 97) . MAVS binds to and activates TRAF2, TRAF3, TRAF5, and TRAF6, which activate the NFk B and MAPK pathways (described above and in Data Set S1 in the supplemental material) (64, 93, 96) . In addition, IKK« and TBK1 phosphorylate the MAVS pLxIS motif, which ultimately results in the activation of IRF3 and IRF7 via a similar mechanism as TRIF and STING (described above) (64, 69, 93) .

Short (10-to 300-bp) double-stranded viral RNA (59 diphosphate or 59 triphosphate) binds to single copies of RIG-I (64, 93, 95) . RIPLET K63-polyubiquitinates the RIG-I C-terminal domain (CTD), and RIG-I homodimerizes (64, 95) . MEX3C, RIPLET, TRIM4, and TRIM25 K63-polyubiquitinate the second RIG-I CARD domain (64, 93, 95, 96) . RIG-I forms homotetramers and homomers, and the RIG-I CARD domains bind to and activate MAVS in a similar manner as MDA5 (64, 93, 95) .

Inflammasomes. Inflammasomes are cytosolic oligomeric sensors of numerous PAMPs. Inflammasomes promote proinflammatory cytokine signaling, they cause programmed cell death, and their structure and function have been recently reviewed in detail (46, 48, (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) . Briefly, inflammasomes are composed of a receptor, an adapter, and an effector. Inflammasome ligand-receptor interactions include double-stranded DNA binding to AIM2, lipoteichoic acid binding to NLRP6, and lipopeptide binding to NLRP7. Some ligand-receptor interactions require an intermediate protein.

For example, NLRP9b activation by double-stranded RNA requires DHX9, and NLRC4 activation by bacterial proteins (flagellin, and the rod and needle from type III secretion systems) requires NAIP. Finally, some ligands activate their receptor using a mechanism other than receptor ligation (e.g., Bacillus anthracis lethal factor cleaves NLRP1B).

Upon ligand binding, the receptor homo-oligomerizes (46, 48, (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) . For example, NAIP-NLRC4 forms either a disk of ;12 monomers (48, 98, 105, 106) or a helix of ;12 monomers per turn (105) . The receptor binds to the adapter protein ASC, which then homo-oligomerizes into a linear chain which might form branches (106) . Two receptors (NLRC4 and NLRP1b) are capable of forming functional inflammasomes with or without ASC. Oligomeric ASC binds to CASP1, which homo-oligomerizes into a linear chain and is activated by trans-autoproteolysis. CASP1 processes and activates GSDMD, which forms pores in the cell membrane. CASP1 also processes the proinflammatory cytokines IL1b and IL-18, which exit the cell via the GSDMD pores. In contrast to the above canonical inflammasomes, the noncanonical inflammasome CASP4/5 directly binds to LPS, is activated by trans-autoproteolysis, and processes GSDMD. For more details, see Data Set S1.

The molecular mechanisms utilized by the TLR and cytosolic PRR pathways are highly diverse. Very characteristic are the oligomeric SMOCs and the branching chains of ubiquitin. It remains unclear what benefit, if any, is derived from the utilization of such large and complex molecular structures in the struggle against pathogens and their virulence factors. Modeling can be used to address these questions, but accurate modeling of these pathways remains challenging.

Molecular interaction networks of the TLR pathway have been published previously (7) (8) (9) (10) (11) (12) (13) (14) , and this review includes a molecular mechanism network of the TLR and cytosolic PRR pathways (see Data Set S1 in the supplemental material). Despite having significant scope and detail, none of these networks are comprehensive, primarily because so many significant pathway components remain obscure. For example, although numerous alternative splice isoform sequences of TLR pathway proteins have been sequenced, many of their functions remain unclear. This is unfortunate because it is likely that many of these isoforms have important physiological roles. For example, it is known that a truncated isoform of MyD88 is dominant negative and plays an important role in preventing chronic inflammation (109) . Other unresolved issues include fully determining the structure-function relationship of branched polyubiquitin and identifying the phosphatases that act on TLR pathway phosphoproteins.

Developing PRR pathway models at molecular interaction level for performing pathway simulations will aid the development of therapeutics for diseases related to the innate immune system (e.g., sepsis), but developing these models will require more than just molecular mechanism networks. Critically, the molecular reaction rates (k on , k off , and k cat ) and reactant concentrations are required. Targeted proteomics has been used to measure protein concentrations to support the development of numerous signaling pathway models (110) . However, measuring the corresponding reaction rates remains challenging, but they can be predicted using bimolecular simulations (111, 112) . These two sets of values can be used as input parameters for pathway modeling and simulation (22, 113) . Importantly, pathway models can be trained using, for example, microscopy data, which is how we trained our model of the mouse macrophage chemotaxis signaling pathway (114) . Although the development of PRR pathway models remains a formidable challenge, they will be necessary for accurately predicting the behavior of these pathways, especially for pathways stimulated by a diverse population of microbes and PAMPs.

Supplemental material is available online only. 

Innate immune pattern recognition: a cell biological perspective

Sepsis and septic shock

Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Microbiomes other than the gut: inflammaging and age-related diseases

PRRDB 2.0: a comprehensive database of pattern-recognition receptors and their ligands. Database (Oxford) 2019:baz076

Detailed qualitative dynamic knowledge representation using a BioNetGen model of TLR-4 signaling and preconditioning

Data-driven modeling identifies TIRAP-independent MyD88 activation complex and myddosome assembly strategy in LPS/TLR4 signaling

Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways

A comprehensive map of the toll-like receptor signaling network

Comprehensive logic based analyses of Toll-like receptor 4 signal transduction pathway

Construction of a large scale integrated map of macrophage pathogen recognition and effector systems

An interactive macrophage signal transduction map facilitates comparative analyses of high-throughput data

Identification of potential pathway mediation targets in Toll-like receptor signaling

Computational identification and analysis of signaling subnetworks with distinct functional roles in the regulation of TNF production

Biomarkers of inflammation and the etiology of sepsis

Host innate immune responses to sepsis

The emerging role of stimulator of interferons genes signaling in sepsis: inflammation, autophagy, and cell death

Epidemiology and immune pathogenesis of viral sepsis

Cytoscape: a software environment for integrated models of biomolecular interaction networks

SBML Level 3 Community members. 2020. SBML level 3: an extensible format for the exchange and reuse of biological models

The Simmune Modeler visual interface for creating signaling networks based on bi-molecular interactions

Global landscape of mouse and human cytokine transcriptional regulation

RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database (Oxford ) 2015:bav095

Understanding early TLR signaling through the Myddosome

TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target

Assembly and localization of Toll-like receptor signalling complexes

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Toll-Like receptors, associated biological roles, and signaling networks in non-mammals

Signalling, sorting and scaffolding adaptors for Toll-like receptors

The non-immune functions of Toll-like receptors

Toll-like receptors and the control of immunity

Toll-like receptor 4: a promising crossroads in the diagnosis and treatment of several pathologies

Infection and atherosclerosis: TLR-dependent pathways

Conservation and divergence of ligand recognition and signal transduction mechanisms in Toll-like receptors

Structural insights into ligand recognition and regulation of nucleic acid-sensing Toll-like receptors

Toward a structural understanding of nucleic acid-sensing Toll-like receptors in the innate immune system

Recent clinical trends in Toll-like receptor targeting therapeutics

Microbial strategies for antagonizing Tolllike-receptor signal transduction

Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity

Mass spectrometry-based structural analysis and systems immunoproteomics strategies for deciphering the host response to endotoxin

Recent advances in lipopolysaccharide recognition systems

TLR4-targeting therapeutics: structural basis and computer-aided drug discovery approaches

Multiscale modeling of innate immune receptors: endotoxin recognition and regulation by host defense peptides

Activation of Toll-like receptors nucleates assembly of the MyDDosome signaling hub

Death, TIR, and RHIM: self-assembling domains involved in innate immunity and cell-death signaling

Structural basis of TIR-domain-assembly formation in MAL-and MyD88-dependent TLR4 signaling

Regulation of signaling by cooperative assembly formation in mammalian innate immunity signalosomes by molecular mimics

Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling

MyD88 death-domain oligomerization determines myddosome architecture: implications for Toll-like receptor signaling

Crystal structure of human IRAK1

Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling

Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptorinterleukin-1 receptor superfamily

Molecular basis of NF-kappaB signaling

The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways

HOIL-1, an atypical E3 ligase that controls MyD88 signalling by forming ester bonds between ubiquitin and components of the Myddosome

Ubiquitin chain diversity at a glance

ERK signalling: a master regulator of cell behaviour, life and fate

NF-kappaB regulation: lessons from structures

Structural basis for the activation of IKK1/ alpha

A structural basis for IkappaB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation

NFKB1 and cancer: friend or foe? Cells 7:133

NF-kappaB, IkappaB, and IKK: integral components of immune system signaling

Detection of microbial infections through innate immune sensing of nucleic acids

Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling

Below the surface: the inner lives of TLR4 and TLR9

Towards the structure of the TIR-domain signalosome

CD137 (4-1BB) signalosome: complexity is a matter of TRAFs

Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation

The evolving role of TRAFs in mediating inflammatory responses

IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex

TBK1, a central kinase in innate immune sensing of nucleic acids and beyond

LPS-TLR4 signaling to IRF-3/7 and NF-kap-paB involves the toll adapters TRAM and TRIF

The molecular basis of viral inhibition of IRFand STAT-dependent immune responses

Innate sense of purpose for IKKbeta

NF-kappaB signaling in inflammation

IRF and STAT transcription factors -from basic biology to roles in infection, protective immunity, and primary immunodeficiencies

To catch a thief: regulated RIPK1 posttranslational modifications as a fail-safe system to detect and overcome pathogen subversion of immune signaling

Yersinia pestis: mechanisms of entry into and resistance to the host cell

Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways

IAP-mediated protein ubiquitination in regulating cell signaling

Complex pathologic roles of RIPK1 and RIPK3: moving beyond necroptosis

To die or not to die: regulatory feedback phosphorylation circuits determine receptor-interacting protein kinase-1 (RIPK1) function

Programmed necrosis and necroptosis signalling

Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy

FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

Multitasking kinase RIPK1 regulates cell death and inflammation

Caspases in cell death, inflammation, and pyroptosis

Ripoptocide -a spark for inflammation

Molecular mechanisms and cellular functions of cGAS-STING signalling

The interactions between cGAS-STING pathway and pathogens

Structures of RIG-I-like receptors and insights into viral RNA sensing

Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5

RIG-I-like receptors: their regulation and roles in RNA sensing

Mitochondrial interactome: a focus on antiviral signaling pathways

Regulation of MAVS expression and signaling function in the antiviral innate immune response

Structural biology of NOD-like receptors

Inflammasomes and the fine line between defense and disease

Emerging activators and regulators of inflammasomes and pyroptosis

Cytosolic recognition of microbes and pathogens: inflammasomes in action

Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases

NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways

Structural and mechanistic elucidation of inflammasome signaling by cryo-EM

From atoms to physiology: what it takes to really understand inflammasomes

Inflammasomes and adaptive immune responses

Inflammasome activation and regulation: toward a better understanding of complex mechanisms

NF-kappaB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages

Application of targeted mass spectrometry in bottom-up proteomics for systems biology research

SDA 7: a modular and parallel implementation of the simulation of diffusional association software

Automated prediction of protein association rate constants

Computational modeling of cellular signaling processes embedded into dynamic spatial contexts

Targeted proteomics-driven computational modeling of macrophage S1P chemosensing